Učitavanje...
Proteasome inhibitor bortezomib is a novel therapeutic agent for focal radiation-induced osteoporosis
Bone atrophy and its related fragility fractures are frequent, late side effects of radiotherapy in cancer survivors and have a detrimental impact on their quality of life. In another study, we showed that parathyroid hormone 1-34 and anti-sclerostin antibody attenuates radiation-induced bone damage...
Spremljeno u:
| Izdano u: | FASEB J |
|---|---|
| Glavni autori: | , , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Federation of American Societies for Experimental Biology
2018
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5731129/ https://ncbi.nlm.nih.gov/pubmed/28860152 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1096/fj.201700375R |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|